Mc. Fonteles et al., Antihyperglycemic effects of 3-O-methyl-D-chiro-inositol and D-chiro-inositol associated with manganese in streptozotocin diabetic rats, HORMONE MET, 32(4), 2000, pp. 129-132
The acute effects after administration of 3-O-Methyl-D-Chiro-inositol, D-Ch
iro-inositol and manganese, components of the pH 2.0 putative mediator of i
nsulin action, on plasma glucose were examined in low dose streptozotocin-t
reated rats. 3-O-Methyl-D-Chiro-inositol at a bolus dose of 5 mg/kg decreas
ed plasma glucose 6% at 120 min (p < 0.05). A higher bolus dose of 3-O-Meth
yl-D-Chiro-inositol (15 mg/kg) promoted a more persistent hypoglycemic effe
ct of 22% at 120 min (p < 0.05). Infusion of 8.3 mu g/min of manganese chlo
ride lowered plasma glucose by 23% (p < 0.05). 3-O-Methyl-D-Chiro-inositol
(15 mg/kg) together with manganese chloride (8.3 mu g/min) promoted a reduc
tion of 49% in 120 min (p < 0.05). D-Chiro-inositol at a bolus dose of 5 mg
/kg had no effect. A single dose of 15 mg/kg produced a reduction of 21% (p
< 0.05) in 120 min. D-Chiro-inositol (15 mg/kg) associated with manganese
chloride (8.3 mu g/min) decreased elevated plasma glucose 47% (p < 0.05) in
120 min. D-Chiro-inositol coadministered with manganese reduced glucose co
ncentrations during the final 60 min (p < 0.05). 3-O-Methyl-D-Chiro-inosito
l and D-chiro-inositol are components of the mediator structure. Manganese
is also a presumed component of the mediator, having an important role in g
lucose uptake, insulin relase and mediator generation. These compounds have
also been identified in the literature as hypogylcemic agents.